NCT01962922View on ClinicalTrials.gov

Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Renal Failure
Interventions
DRUG

LCP-Tacro

once-daily extended release tablet

DRUG

Tacrolimus -IR

twice daily capsules

Trial Locations (3)

19104

Hospital of the University of Pennsylvania, Philadelphia

60612

University of Illinois, Chicago, Chicago

63110

Washingto University School of Medicine, St Louis

Sponsors
All Listed Sponsors
lead

Veloxis Pharmaceuticals

INDUSTRY